Background Pediatric mitral valve (MV) disease encompasses a heterogeneous group of congenital and acquired conditions, and its surgical management remains one of the most technically demanding areas of congenital heart surgery. Evidence guiding surgical decision-making is derived largely from single-center series, and contemporary, multi-institutional data on practice patterns and outcomes remain scarce. Aim of the study This study characterizes contemporary practice patterns and outcomes in pediatric MV surgery across the European Congenital Heart Surgeons Association Congenital Database (ECHSA-CD). Materials and methods We conducted a retrospective, multi-institutional analysis using ECHSA-CD. The cohort included 6,736 patients < 18 years who underwent MV surgery (01/01/2003–12/31/2024). Exclusion criteria were atrioventricular septal defects, functionally univentricular physiology, and non-systemic MV. Multivariable logistic regression was used to identify independent predictors of in-hospital mortality and postoperative complications, and receiver operating characteristic analysis was used to identify body-weight thresholds associated with mortality risk. Results The primary etiology was MV dysplasia (5,916/6,736; 87.8%), and regurgitation was the predominant hemodynamic mechanism (4,284/5,548; 77.2%). MV repair was the most common surgical strategy (5,513/6,736; 81.8%), and, while MV repair predominated across all age groups, the frequency of mitral valve replacement (MVR) increased with advancing age. Overall, in-hospital mortality rate was 245/6,736 (3.6%), with a significant reduction observed in the most recent decade (130/2,814; 4.6% versus 115/3,922; 2.9%; p < 0.001). In-hospital mortality was significantly elevated among neonates (unadjusted odds ratio (OR): 14.8; 95% confidence interval (CI): 9.86-22.2; p < 0.001), patients with MV stenosis (OR: 1.83; 95% CI: 1.22-2.73; p = 0.003), and those receiving MVR (OR: 4.01; 95% CI: 2.74-5.87; p < 0.001), or undergoing intraoperative conversion from repair to replacement (OR: 6.65; 95% CI: 2.42-18.3; p < 0.001). Receiver operating characteristic analysis identified critical weight thresholds for mortality at 5.8 kg for the overall cohort (area under the curve [AUC]: 0.74; 95% CI: 0.70-0.77; p < 0.001) and 12.6 kg in MVR (AUC: 0.74; 95% CI: 0.67-0.80; p < 0.001). Conclusions Pediatric MV surgery outcomes have significantly improved over time. However, the procedure remains a high-risk intervention specifically for infants, where low body weight is one of the primary drivers of adverse outcomes.
Background Pediatric mitral valve (MV) disease encompasses a heterogeneous group of congenital and acquired conditions, and its surgical management remains one of the most technically demanding areas of congenital heart surgery. Evidence guiding surgical decision-making is derived largely from single-center series, and contemporary, multi-institutional data on practice patterns and outcomes remain scarce. Aim of the study This study characterizes contemporary practice patterns and outcomes in pediatric MV surgery across the European Congenital Heart Surgeons Association Congenital Database (ECHSA-CD). Materials and methods We conducted a retrospective, multi-institutional analysis using ECHSA-CD. The cohort included 6,736 patients < 18 years who underwent MV surgery (01/01/2003–12/31/2024). Exclusion criteria were atrioventricular septal defects, functionally univentricular physiology, and non-systemic MV. Multivariable logistic regression was used to identify independent predictors of in-hospital mortality and postoperative complications, and receiver operating characteristic analysis was used to identify body-weight thresholds associated with mortality risk. Results The primary etiology was MV dysplasia (5,916/6,736; 87.8%), and regurgitation was the predominant hemodynamic mechanism (4,284/5,548; 77.2%). MV repair was the most common surgical strategy (5,513/6,736; 81.8%), and, while MV repair predominated across all age groups, the frequency of mitral valve replacement (MVR) increased with advancing age. Overall, in-hospital mortality rate was 245/6,736 (3.6%), with a significant reduction observed in the most recent decade (130/2,814; 4.6% versus 115/3,922; 2.9%; p < 0.001). In-hospital mortality was significantly elevated among neonates (unadjusted odds ratio (OR): 14.8; 95% confidence interval (CI): 9.86-22.2; p < 0.001), patients with MV stenosis (OR: 1.83; 95% CI: 1.22-2.73; p = 0.003), and those receiving MVR (OR: 4.01; 95% CI: 2.74-5.87; p < 0.001), or undergoing intraoperative conversion from repair to replacement (OR: 6.65; 95% CI: 2.42-18.3; p < 0.001). Receiver operating characteristic analysis identified critical weight thresholds for mortality at 5.8 kg for the overall cohort (area under the curve [AUC]: 0.74; 95% CI: 0.70-0.77; p < 0.001) and 12.6 kg in MVR (AUC: 0.74; 95% CI: 0.67-0.80; p < 0.001). Conclusions Pediatric MV surgery outcomes have significantly improved over time. However, the procedure remains a high-risk intervention specifically for infants, where low body weight is one of the primary drivers of adverse outcomes.
Pediatric Mitral Valve Surgery: Current Practice from the European Congenital Heart Surgeons Association Congenital Database
CATTAPAN, CLAUDIA
2024/2025
Abstract
Background Pediatric mitral valve (MV) disease encompasses a heterogeneous group of congenital and acquired conditions, and its surgical management remains one of the most technically demanding areas of congenital heart surgery. Evidence guiding surgical decision-making is derived largely from single-center series, and contemporary, multi-institutional data on practice patterns and outcomes remain scarce. Aim of the study This study characterizes contemporary practice patterns and outcomes in pediatric MV surgery across the European Congenital Heart Surgeons Association Congenital Database (ECHSA-CD). Materials and methods We conducted a retrospective, multi-institutional analysis using ECHSA-CD. The cohort included 6,736 patients < 18 years who underwent MV surgery (01/01/2003–12/31/2024). Exclusion criteria were atrioventricular septal defects, functionally univentricular physiology, and non-systemic MV. Multivariable logistic regression was used to identify independent predictors of in-hospital mortality and postoperative complications, and receiver operating characteristic analysis was used to identify body-weight thresholds associated with mortality risk. Results The primary etiology was MV dysplasia (5,916/6,736; 87.8%), and regurgitation was the predominant hemodynamic mechanism (4,284/5,548; 77.2%). MV repair was the most common surgical strategy (5,513/6,736; 81.8%), and, while MV repair predominated across all age groups, the frequency of mitral valve replacement (MVR) increased with advancing age. Overall, in-hospital mortality rate was 245/6,736 (3.6%), with a significant reduction observed in the most recent decade (130/2,814; 4.6% versus 115/3,922; 2.9%; p < 0.001). In-hospital mortality was significantly elevated among neonates (unadjusted odds ratio (OR): 14.8; 95% confidence interval (CI): 9.86-22.2; p < 0.001), patients with MV stenosis (OR: 1.83; 95% CI: 1.22-2.73; p = 0.003), and those receiving MVR (OR: 4.01; 95% CI: 2.74-5.87; p < 0.001), or undergoing intraoperative conversion from repair to replacement (OR: 6.65; 95% CI: 2.42-18.3; p < 0.001). Receiver operating characteristic analysis identified critical weight thresholds for mortality at 5.8 kg for the overall cohort (area under the curve [AUC]: 0.74; 95% CI: 0.70-0.77; p < 0.001) and 12.6 kg in MVR (AUC: 0.74; 95% CI: 0.67-0.80; p < 0.001). Conclusions Pediatric MV surgery outcomes have significantly improved over time. However, the procedure remains a high-risk intervention specifically for infants, where low body weight is one of the primary drivers of adverse outcomes.| File | Dimensione | Formato | |
|---|---|---|---|
|
Tesi_cch_Cattapan.pdf
Accesso riservato
Dimensione
1.86 MB
Formato
Adobe PDF
|
1.86 MB | Adobe PDF |
The text of this website © Università degli studi di Padova. Full Text are published under a non-exclusive license. Metadata are under a CC0 License
https://hdl.handle.net/20.500.12608/120609